Morbidity and survival probability in burn patients in modern burn care
- PMID: 25559438
- PMCID: PMC4359665
- DOI: 10.1097/CCM.0000000000000790
Morbidity and survival probability in burn patients in modern burn care
Abstract
Objective: Characterizing burn sizes that are associated with an increased risk of mortality and morbidity is critical because it would allow identifying patients who might derive the greatest benefit from individualized, experimental, or innovative therapies. Although scores have been established to predict mortality, few data addressing other outcomes exist. The objective of this study was to determine burn sizes that are associated with increased mortality and morbidity after burn.
Design and patients: Burn patients were prospectively enrolled as part of the multicenter prospective cohort study, Inflammation and the Host Response to Injury Glue Grant, with the following inclusion criteria: 0-99 years old, admission within 96 hours after injury, and more than 20% total body surface area burns requiring at least one surgical intervention.
Setting: Six major burn centers in North America.
Measurements and main results: Burn size cutoff values were determined for mortality, burn wound infection (at least two infections), sepsis (as defined by American Burn Association sepsis criteria), pneumonia, acute respiratory distress syndrome, and multiple organ failure (Denver 2 score>3) for both children (<16 yr) and adults (16-65 yr). Five hundred seventy-three patients were enrolled, of which 226 patients were children. Twenty-three patients were older than 65 years and were excluded from the cutoff analysis. In children, the cutoff burn size for mortality, sepsis, infection, and multiple organ failure was approximately 60% total body surface area burned. In adults, the cutoff for these outcomes was lower, at approximately 40% total body surface area burned.
Conclusions: In the modern burn care setting, adults with over 40% total body surface area burned and children with over 60% total body surface area burned are at high risk for morbidity and mortality, even in highly specialized centers.
Conflict of interest statement
Figures
Comment in
-
Can we really predict morbidity and mortality in burn patients?Crit Care Med. 2015 Apr;43(4):918-9. doi: 10.1097/CCM.0000000000000842. Crit Care Med. 2015. PMID: 25768358 No abstract available.
Similar articles
-
Comparative Usefulness of Sepsis-3, Burn Sepsis, and Conventional Sepsis Criteria in Patients With Major Burns.Crit Care Med. 2018 Jul;46(7):e656-e662. doi: 10.1097/CCM.0000000000003144. Crit Care Med. 2018. PMID: 29620554
-
Early leukocyte gene expression associated with age, burn size, and inhalation injury in severely burned adults.J Trauma Acute Care Surg. 2016 Feb;80(2):250-7. doi: 10.1097/TA.0000000000000905. J Trauma Acute Care Surg. 2016. PMID: 26517785 Free PMC article.
-
Mortality risk and length of stay associated with self-inflicted burn injury: evidence from a national sample of 30,382 adult patients.Crit Care Med. 2008 Jan;36(1):118-25. doi: 10.1097/01.CCM.0000293122.43433.72. Crit Care Med. 2008. PMID: 18090371
-
Standardised mortality ratio based on the sum of age and percentage total body surface area burned is an adequate quality indicator in burn care: An exploratory review.Burns. 2016 Feb;42(1):28-40. doi: 10.1016/j.burns.2015.10.032. Epub 2015 Dec 14. Burns. 2016. PMID: 26700877 Review.
-
[Immunology and sepsis syndrome in burn trauma].Unfallchirurg. 2009 May;112(5):472-8. doi: 10.1007/s00113-009-1652-8. Unfallchirurg. 2009. PMID: 19440644 Review. German.
Cited by
-
Mortality incidence among critically ill burn patients infected with multidrug-resistant organisms: A retrospective cohort study.Scars Burn Heal. 2021 May 25;7:20595131211015133. doi: 10.1177/20595131211015133. eCollection 2021 Jan-Dec. Scars Burn Heal. 2021. PMID: 34104480 Free PMC article.
-
Intestine immune homeostasis after alcohol and burn injury.Shock. 2015 Jun;43(6):540-8. doi: 10.1097/SHK.0000000000000353. Shock. 2015. PMID: 25692258 Free PMC article. Review.
-
Age and Injury Size Influence the Magnitude of Fecal Dysbiosis in Adult Burn Patients.J Burn Care Res. 2022 Sep 1;43(5):1145-1153. doi: 10.1093/jbcr/irac001. J Burn Care Res. 2022. PMID: 35020913 Free PMC article.
-
Selective Intestinal Decontamination as a Method for Preventing Infectious Complications (Review).Sovrem Tekhnologii Med. 2021;12(6):86-95. doi: 10.17691/stm2020.12.6.10. Epub 2020 Dec 28. Sovrem Tekhnologii Med. 2021. PMID: 34796022 Free PMC article. Review.
-
Population Pharmacokinetic Modeling and Simulations of Imipenem in Burn Patients With and Without Continuous Venovenous Hemofiltration in the Military Health System.J Clin Pharmacol. 2021 Sep;61(9):1182-1194. doi: 10.1002/jcph.1865. Epub 2021 Jun 19. J Clin Pharmacol. 2021. PMID: 33811332 Free PMC article.
References
-
- Hussain A, Choukairi F, Dunn K. Predicting survival in thermal injury: A systematic review of methodology of composite prediction models. Burns. 2013 Feb 2; Epub ahead of print. - PubMed
-
- Roberts G, Lloyd M, Parker M, et al. The Baux score is dead. Long live the Baux score: a 27-year retrospective cohort study of mortality at a regional burns service. J Trauma Acute Care Surg. 2012;72:251–256. - PubMed
-
- Choiniere M, Dumont M, Papillon J, et al. Prediction of death in patients with burns. Lancet. 1999;353:2211–2212. - PubMed
-
- Germann G, Barthold U, Lefering R, et al. The impact of risk factors and pre-existing conditions on the mortality of burn patients and the precision of predictive admission-scoring systems. Burns. 1997;23:195–203. - PubMed
Publication types
MeSH terms
Grants and funding
- U54 GM062119/GM/NIGMS NIH HHS/United States
- T32 GM0008256/GM/NIGMS NIH HHS/United States
- R24 GM102656/GM/NIGMS NIH HHS/United States
- UL1TR000071/TR/NCATS NIH HHS/United States
- KL2 RR029875/RR/NCRR NIH HHS/United States
- KL2RR029875/RR/NCRR NIH HHS/United States
- UL1 TR000071/TR/NCATS NIH HHS/United States
- U54 GM62119/GM/NIGMS NIH HHS/United States
- R01 GM056687/GM/NIGMS NIH HHS/United States
- P50 GM060338/GM/NIGMS NIH HHS/United States
- T32 GM008256/GM/NIGMS NIH HHS/United States
- 123336/Canadian Institutes of Health Research/Canada
- R01 GM087285/GM/NIGMS NIH HHS/United States
- UL1 RR029876/RR/NCRR NIH HHS/United States
- UL1RR029876/RR/NCRR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical